AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Neuberger Berman High Yield Strategies Fund Announces $7.44/share Purchase
ByAinvest
Friday, May 30, 2025 7:21 pm ET1min read
Neuberger Berman High Yield Strategies Fund Inc. (NHS) has recently disclosed that Christopher Kocinski has made a significant investment in the company. On May 29, 2025, Kocinski acquired 15,000 shares at a per-share price of $7.44.
On May 29, 2025, Christopher Kocinski, a director and portfolio manager at Neuberger Berman Investment Advisers LLC, acquired 15,000 shares of Neuberger Berman High Yield Strategies Fund Inc. (NHS) at a per-share price of $7.44 [1]. This transaction was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission (SEC).NHS is a closed-ended fixed income mutual fund that invests in high yield debt securities across various sectors, including auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom-integrated/services, gaming, and gas distribution. The fund, managed by Neuberger Berman Investment Advisers LLC, was launched on July 28, 2003 [3].
The acquisition of shares by Kocinski, who is a key figure in the fund's management, indicates a level of confidence in the fund's prospects. This aligns with the broader trend of insider buying, as seen in other recent transactions involving high-profile insiders such as Jeffrey Yurcisin, President & CEO of Grove Collaborative Holdings Inc., who purchased 15,000 shares of his company on May 23, 2025 [2].
The stock's recent performance has been mixed, with shares crossing below their 200-day moving average on May 28, 2025. However, the fund's dividend policy remains attractive, with a monthly dividend of $0.0905, representing a $1.09 annualized dividend and a dividend yield of 14.72% [4]. This suggests that the fund continues to offer a compelling investment proposition despite recent market fluctuations.
References:
[1] https://www.streetinsider.com/SEC+Filings/Form+4+Neuberger+Berman+High+For%3A+May+29+Filed+by%3A+Kocinski+Chris/24879207.html
[2] https://www.gurufocus.com/news/2890394/insider-buying-jeffrey-yurcisin-acquires-15000-shares-of-grove-collaborative-holdings-inc-grov
[3] https://finance.yahoo.com/quote/NHS/
[4] https://www.marketbeat.com/instant-alerts/neuberger-berman-high-yield-strategies-fund-nyseamericannhs-shares-pass-below-200-day-moving-average-heres-what-happened-2025-05-28/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet